...
首页> 外文期刊>Neuropathology and applied neurobiology >Implementation of a multi-institutional diffuse intrinsic pontine glioma autopsy protocol and characterization of a primary cell culture
【24h】

Implementation of a multi-institutional diffuse intrinsic pontine glioma autopsy protocol and characterization of a primary cell culture

机译:多机构弥漫性桥脑神经胶质瘤尸体解剖多协议的实施和原代细胞培养的表征

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aims: Diffuse intrinsic pontine glioma (DIPG) is a fatal paediatric malignancy. Tumour resection is not possible without serious morbidity and biopsies are rarely performed. The resulting lack of primary DIPG material has made preclinical research practically impossible and has hindered the development of new therapies for this disease. The aim of the current study was to address the lack of primary DIPG material and preclinical models by developing a multi-institutional autopsy protocol. Methods: An autopsy protocol was implemented in the Netherlands to obtain tumour material within a brief post mortem interval. A team of neuropathologists and researchers was available at any time to perform the autopsy and process the material harvested. Whole brain autopsy was performed and primary DIPG material and healthy tissue were collected from all affected brain areas. Finally, the study included systematic evaluation by parents. Results: Five autopsies were performed. The mean time interval between death and time of autopsy was 3h (range 2-4). All tumours were graded as glioblastoma. None of the parents regretted their choice to participate, and they all derived comfort in donating tissue of their child in the hope to help future DIPG patients. In addition, we developed and characterized one of the first DIPG cell cultures from post mortem material. Conclusion: Here we show that obtaining post mortem DIPG tumour tissue for research purposes is feasible with short delay, and that the autopsy procedure is satisfying for participating parents and can be suitable for the development of preclinical DIPG models.
机译:目的:弥漫性桥脑神经胶质瘤(DIPG)是一种致命的儿科恶性肿瘤。没有严重的发病率就不可能进行肿瘤切除,并且很少进行活检。结果导致缺乏主要的DIPG材料,实际上使临床前研究变得不可能,并且阻碍了该疾病的新疗法的开发。当前研究的目的是通过开发多机构尸检协议来解决缺乏主要DIPG材料和临床前模型的问题。方法:在荷兰实施了尸检协议,以在短暂的验尸间隔内获得肿瘤材料。随时都有神经病理学家和研究人员团队进行尸检和处理所采集的材料。进行了全脑解剖,并从所有受影响的大脑区域收集了主要的DIPG物质和健康组织。最后,该研究包括父母的系统评价。结果:进行了五次尸检。死亡与尸检时间之间的平均时间间隔为3h(范围2-4)。所有肿瘤均被分类为胶质母细胞瘤。没有父母会后悔选择参加,他们都为孩子的组织捐赠而感到安慰,希望能帮助将来的DIPG患者。此外,我们从验尸材料中开发并鉴定了首批DIPG细胞培养物之一。结论:在这里我们表明,为研究目的获得死后DIPG肿瘤组织是可行的,且延迟时间短,并且尸​​体解剖程序对于参与的父母来说是令人满意的,并且适合于临床前DIPG模型的开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号